Shareholder Tools

Press Releases

2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 1999
Press Releases
Date Title and Summary View
Sep 29, 2016 WEST LAFAYETTE, Ind., Sept. 29, 2016 (GLOBE NEWSWIRE) -- Endocyte, Inc. (NASDAQ:ECYT), a leader in developing targeted small molecule drug conjugates (SMDCs) and companion imaging agents for personalized therapy, today announced that two posters will be presented at the European Society for Medical Oncology (ESMO), being held in Copenhagen, Denma...
Sep 20, 2016 WEST LAFAYETTE, Ind., Sept. 20, 2016 (GLOBE NEWSWIRE) -- Endocyte, Inc. (NASDAQ:ECYT), a leader in developing targeted small molecule drug conjugates (SMDCs) and companion imaging agents for personalized therapy, today announced that the company's management team will present at the Ladenburg Thalmann 2016 Healthcare Conference on Tuesday, Sept. ...
Aug 15, 2016 WEST LAFAYETTE, Ind., Aug. 15, 2016 (GLOBE NEWSWIRE) -- Endocyte, Inc. (NASDAQ:ECYT), a leader in developing targeted small molecule drug conjugates (SMDCs) and companion imaging agents for personalized therapy, today announced that five posters will be presented by Endocyte scientists at the 252nd American Chemical Society (ACS) National Meeting...
Aug 9, 2016 WEST LAFAYETTE, Ind., Aug. 09, 2016 (GLOBE NEWSWIRE) -- Endocyte, Inc. (NASDAQ:ECYT), a leader in developing targeted small molecule drug conjugates (SMDCs) and companion imaging agents for personalized therapy, today announced that the company's management team will present at the 2016 Wedbush PacGrow Healthcare Conference on Tuesday, Aug. 16, a...
Aug 4, 2016 - Reached Maximum Tolerated Dose in Twice Weekly Dosing Schedule with EC1456 - - Initiating EC1456 Expansion Cohort in Targeted Population of Folate Receptor-Positive Non-Small Cell Lung Cancer Patients - - Data Presentations Expected for EC1456 and EC1169 in the Second Half of 2016 - - Conference Call Today at 4:30 p.m. EDT - WEST LAFAYETT...
Jul 28, 2016 WEST LAFAYETTE, Ind., July 28, 2016 (GLOBE NEWSWIRE) -- Endocyte, Inc., (NASDAQ:ECYT) announced today that the company will host a conference call on Thursday, August 4th, at 4:30 p.m. EDT to discuss its second quarter financial results and provide an operational update. Investors and the general public are invited to listen to a live webcas...
Jun 20, 2016 WEST LAFAYETTE, Ind., June 20, 2016 (GLOBE NEWSWIRE) -- Endocyte, Inc. (NASDAQ:ECYT), a leader in developing targeted small molecule drug conjugates (SMDCs) and companion imaging agents for personalized therapy, today announced that Mike Sherman has been appointed president and chief executive officer of the Company and added to its board of dire...
May 26, 2016 WEST LAFAYETTE, Ind., May 26, 2016 (GLOBE NEWSWIRE) -- Endocyte, Inc. (NASDAQ:ECYT), a leader in developing targeted small molecule drug conjugates (SMDCs) and companion imaging agents for personalized therapy, today announced that two posters will be presented on its lead, clinical-stage assets, EC1456 and EC1169, at the 2016 American Society of...
May 4, 2016 - Data from Phase 1 Dose Escalation Studies of EC1456 and EC1169 to be Presented at ASCO - - Expansion Phase of Trials in Targeted Patients Expected to Yield Efficacy Data in 2016 -- Promising Preclinical Data Demonstrates Unique SMDC Applications in Immuno-Oncology -       - Conference Call Today at 8:30 a.m. EDT - WEST LAFAYETTE, Ind., May 04...
Apr 27, 2016 WEST LAFAYETTE, Ind., April 27, 2016 (GLOBE NEWSWIRE) -- Endocyte, Inc., (NASDAQ:ECYT) announced today that the company will host a conference call on Wednesday, May 4th, at 8:30 a.m. EDT to discuss its first quarter financial results and provide an operational update. Investors and the general public are invited to listen to a live webcast ...
1
... NextLast
Add to Briefcase = add release to Briefcase